Evidence map›Paper›PMID 39125389›Full record

ReviewNutrients2024

Methylsulfinyl Hexyl Isothiocyanate (6-MSITC) from Wasabi Is a Promising Candidate for the Treatment of Cancer, Alzheimer's Disease, and Obesity.

Joanna Bartkowiak-Wieczorek, Michał Malesza, Ida Malesza, Tomasz Hadada, Jakub Winkler-Galicki, Teresa Grzelak, Edyta Mądry

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Glucosinolate Derivatives: Emerging Anti-Inflammatory Agents.Pharmaceuticals (Basel, Switzerland) · 2026
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Joanna Bartkowiak-WieczorekPhysiology Department, Poznan University of Medical Sciences, 6, Święcickiego Street, 60-781 Poznan, Poland.ORCID 0000-0002-8347-0512
Michał MaleszaPhysiology Department, Poznan University of Medical Sciences, 6, Święcickiego Street, 60-781 Poznan, Poland.ORCID 0000-0003-1183-5938
Ida MaleszaDepartment of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, 61-701 Poznan, Poland.ORCID 0000-0001-6740-8818
Tomasz HadadaPhysiology Department, Poznan University of Medical Sciences, 6, Święcickiego Street, 60-781 Poznan, Poland.ORCID 0000-0002-3230-8662
Jakub Winkler-GalickiPhysiology Department, Poznan University of Medical Sciences, 6, Święcickiego Street, 60-781 Poznan, Poland.ORCID 0000-0003-1415-6252
Teresa GrzelakPhysiology Department, Poznan University of Medical Sciences, 6, Święcickiego Street, 60-781 Poznan, Poland.ORCID 0000-0002-2815-0372
Edyta MądryPhysiology Department, Poznan University of Medical Sciences, 6, Święcickiego Street, 60-781 Poznan, Poland.ORCID 0000-0002-0081-6558

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methylsulfinyl hexyl isothiocyanate (6-MSITC) isolated from

Indexed as

Alzheimer DiseaseIsothiocyanatesNeoplasmsObesityWasabiaAnimalsAnti-Inflammatory AgentsAntioxidantsHumansNeuroprotective AgentsSignal TransductionAnti-Inflammatory AgentsAntioxidantsIsothiocyanatesNeuroprotective AgentsAMPKbreast cancerchronic fatigue syndromecolorectal-stomach cancerERKMAPKmTORNrfParkinson’s diseasePPAR

Identifiers

PMID39125389
PMCPMC11313713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.